Occudo Quantitative Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-143,703
Closed -$3.62M 837
2025
Q1
$3.62M Buy
143,703
+91,137
+173% +$2.38M 0.48% 46
2024
Q4
$1.39M Buy
+52,566
New +$1.43M 0.25% 104
2024
Q2
Sell
-36,009
Closed -$999K 941
2024
Q1
$999K Buy
+36,009
New +$999K 0.17% 159
2023
Q4
Sell
-16,123
Closed -$535K 1102
2023
Q3
$535K Buy
+16,123
New +$570K 0.07% 467
2023
Q2
Sell
-47,246
Closed -$1.93M 1219
2023
Q1
$1.93M Buy
+47,246
New +$2.04M 0.17% 165
2022
Q3
Sell
-16,031
Closed -$841K 1361
2022
Q2
$841K Buy
+16,031
New +$817K 0.07% 440
2022
Q1
Sell
-54,634
Closed -$3.23M 1277
2021
Q4
$3.23M Buy
+54,634
New +$2.71M 0.29% 77
2021
Q2
Sell
-61,431
Closed -$2.23M 1013
2021
Q1
$2.23M Buy
61,431
+30,657
+100% +$1.09M 0.49% 21
2020
Q4
$1.13M Buy
+30,774
New +$1.13M 0.36% 47

Other funds holding PFE

Occudo Quantitative Strategies's PFE Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Pfizer (PFE) in Q2 2025, closing a stake of 143,703 shares — an estimated $3.62M sold.

Occudo Quantitative Strategies first reported a position in PFE in Q4 2020 and held it in 9 quarters. The position peaked at $3.62M in Q1 2025. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 143,703 Pfizer shares in Q2 2025, an estimated $3.62M.
  • Occudo Quantitative Strategies first reported a position in Pfizer in Q4 2020 and held it in 9 quarters.
  • Occudo Quantitative Strategies's Pfizer position peaked at $3.62M in Q1 2025.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.